NL-OMON39557已完成2 期
Phase II trial of the combination of gemcitabine and 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastoma - MIBG-Gem
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •- relapsed or progressive neuroblastoma
- •- age 1 up to 18 years
- •- measurable or evaluable disease
- •- evidence of sufficient MIBG uptake in bone or soft tissue
- •-lansky play score > 70 or ECOG 1
- •- adequate organ function
- •- life expectancy > 6 weeks
- •- wash out of prior therapy of 3 weeks; (1 week if vincristine, 6 weeks in case of nitrosureas); 6 months in case of ASCT
- •- written informed consent
排除标准
- •-other anti-tumour therapy
- •- symptomatic brain metastasis
- •- contra-indication for nuclear isolation
- •- hypersensitivity to gemcitabine
研究者
相似试验
进行中（未招募）
不适用
A phase II study of the combination of gemcitabine with 131I-MIBG therapy for children with neuroblastoma without other treatment options.relapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsEUCTR2007-007974-45-NLAMC47
未知
1 期
Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerPreaviously untreated advanced advanced squamous cell lung cancerJPRN-C000000439Department of Respiratory Medicine of Kyoto University Hospital32
已完成
不适用
Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerung squamous cell carcinomaJPRN-UMIN000004833First Department of Surgery, Hamamatsu University School of Medicine25
进行中（未招募）
不适用
Phase II trial of the addition of gemcitabine to 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomarelapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsEUCTR2007-007974-45-DEAMC47
招募中
不适用
A phase II study of the combination of gemcitabine with 131I-MIBG therapy for children with neuroblastoma without other treatment options.neuroblastoma, children, relapsed, progressiveNL-OMON24917Academisch Medisch Centrum Amsterdam66